SARS-CoV-2 and chronic myeloid leukemia: a systematic review Article Swipe
Elrazi Ali
,
Anas Al-Sadi
,
Qusai Al-maharmeh
,
Eihab A. Subahi
,
Amulya Bellamkonda
,
Madhumati Kalavar
,
Kalpana Panigrahi
,
Awni Alshurafa
,
Mohamed A. Yassin
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3389/fmed.2023.1280271
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3389/fmed.2023.1280271
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus causing the coronavirus disease of 2019. The disease has caused millions of deaths since the first pandemic at the end of 2019. Immunocompromised individuals are more likely to develop severe infections. Numerous mutations had developed in SARS-CoV-2, resulting in strains (Alfa Beta Delta Omicron) with varying degrees of virulence disease severity. In CML (chronic myeloid leukemia) patients, there is a lot of controversy regarding the effect of the treatment on the patient outcome. Some reports suggested potential better outcomes among patients with CML, likely due to the use of TKI; other reports showed no significant effects. Additionally, it is unknown how much protection immunization provides for cancer patients. Method In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards, we conducted a systematic review. Retrospective, prospective studies, reviews, case series, and case reports of chronic myeloid leukemia patients aged above 18 years who had SARS-CoV-2 infection were included. English literature was screened using PubMed, SCOPUS, and Google Scholar. Search terms include chronic myeloid leukemia, chronic myelogenous leukemia, and SARS-CoV-2 and Coronavirus disease 2019 (COVID-19). We searched the reference lists of the included studies for any new articles. The search included all articles published up to April 20, 2023. The review is registered in PROSPERO (registration number CRD42022326674). Results We reviewed 33 articles of available published literature up to April 2023 and collected data from a total of 682 CML patients with COVID-19. Most patients were in the chronic phase, seven were in the accelerated phase, and eight were in the blast phase. Disease severity was classified according to WHO criteria. Mortality was seen in 45 patients, and there were no reports of thrombotic events. Two hundred seventy-seven patients were in the era before vaccination; among them, eight were in the intensive care unit (ICU), and mortality was 30 (11%). There were 405 patients after the era of vaccination; among them, death was reported in 15 (4%) patients and ICU in 13 patients. Limitations and conclusion The major limitation of this review is the lack of details about the use or hold of TKIs during SARS-CoV-2 infection. Additionally, after the appearance of the different variants of the SARS-CoV-2 virus, few studies mentioned the variant of the virus, which makes it difficult to compare the outcome of the other variants of the SARS-CoV-2 virus in patients with CML. Despite the limitations of the study, CML patients with COVID-19 have no significant increase in mortality compared to other hematological malignancy. Hematological cancers are associated with an increased risk of thrombosis, which is expected to increase in patients with COVID-19. However, patient with CML has not been reported to have a significant increase in thrombosis risk. The available data indicates that COVID-19’s effect on patients with chronic myeloid leukemia (CML) still needs to be better understood due to the limited data. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/display_record.php? RecordID:326674.
Related Topics
Concepts
Medicine
Myeloid leukemia
Chronic myelogenous leukemia
Systematic review
Disease
Leukemia
Internal medicine
Pandemic
Cancer
MEDLINE
Intensive care medicine
Immunology
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Political science
Law
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.3389/fmed.2023.1280271
- https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=False
- OA Status
- gold
- Cited By
- 2
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4391172843
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4391172843Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fmed.2023.1280271Digital Object Identifier
- Title
-
SARS-CoV-2 and chronic myeloid leukemia: a systematic reviewWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-24Full publication date if available
- Authors
-
Elrazi Ali, Anas Al-Sadi, Qusai Al-maharmeh, Eihab A. Subahi, Amulya Bellamkonda, Madhumati Kalavar, Kalpana Panigrahi, Awni Alshurafa, Mohamed A. YassinList of authors in order
- Landing page
-
https://doi.org/10.3389/fmed.2023.1280271Publisher landing page
- PDF URL
-
https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=FalseDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=FalseDirect OA link when available
- Concepts
-
Medicine, Myeloid leukemia, Chronic myelogenous leukemia, Systematic review, Disease, Leukemia, Internal medicine, Pandemic, Cancer, MEDLINE, Intensive care medicine, Immunology, Coronavirus disease 2019 (COVID-19), Infectious disease (medical specialty), Political science, LawTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4391172843 |
|---|---|
| doi | https://doi.org/10.3389/fmed.2023.1280271 |
| ids.doi | https://doi.org/10.3389/fmed.2023.1280271 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38327268 |
| ids.openalex | https://openalex.org/W4391172843 |
| fwci | 1.93239349 |
| type | review |
| title | SARS-CoV-2 and chronic myeloid leukemia: a systematic review |
| biblio.issue | |
| biblio.volume | 10 |
| biblio.last_page | 1280271 |
| biblio.first_page | 1280271 |
| topics[0].id | https://openalex.org/T11215 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Chronic Myeloid Leukemia Treatments |
| topics[1].id | https://openalex.org/T10309 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9958000183105469 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2720 |
| topics[1].subfield.display_name | Hematology |
| topics[1].display_name | Acute Myeloid Leukemia Research |
| topics[2].id | https://openalex.org/T10950 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9948999881744385 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2739 |
| topics[2].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[2].display_name | Acute Lymphoblastic Leukemia research |
| is_xpac | False |
| apc_list.value | 2490 |
| apc_list.currency | USD |
| apc_list.value_usd | 2490 |
| apc_paid.value | 2490 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2490 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8142746090888977 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2778729363 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7563463449478149 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11688946 |
| concepts[1].display_name | Myeloid leukemia |
| concepts[2].id | https://openalex.org/C2776960273 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5642129182815552 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q729735 |
| concepts[2].display_name | Chronic myelogenous leukemia |
| concepts[3].id | https://openalex.org/C189708586 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5241824984550476 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1504425 |
| concepts[3].display_name | Systematic review |
| concepts[4].id | https://openalex.org/C2779134260 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5199912190437317 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[4].display_name | Disease |
| concepts[5].id | https://openalex.org/C2778461978 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4524187445640564 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[5].display_name | Leukemia |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.44380003213882446 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C89623803 |
| concepts[7].level | 5 |
| concepts[7].score | 0.43466565012931824 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[7].display_name | Pandemic |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4258824586868286 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C2779473830 |
| concepts[9].level | 2 |
| concepts[9].score | 0.38592982292175293 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1540899 |
| concepts[9].display_name | MEDLINE |
| concepts[10].id | https://openalex.org/C177713679 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3575984239578247 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[10].display_name | Intensive care medicine |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3468424081802368 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C3008058167 |
| concepts[12].level | 4 |
| concepts[12].score | 0.20880764722824097 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[12].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[13].id | https://openalex.org/C524204448 |
| concepts[13].level | 3 |
| concepts[13].score | 0.16462552547454834 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[13].display_name | Infectious disease (medical specialty) |
| concepts[14].id | https://openalex.org/C17744445 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[14].display_name | Political science |
| concepts[15].id | https://openalex.org/C199539241 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[15].display_name | Law |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8142746090888977 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/myeloid-leukemia |
| keywords[1].score | 0.7563463449478149 |
| keywords[1].display_name | Myeloid leukemia |
| keywords[2].id | https://openalex.org/keywords/chronic-myelogenous-leukemia |
| keywords[2].score | 0.5642129182815552 |
| keywords[2].display_name | Chronic myelogenous leukemia |
| keywords[3].id | https://openalex.org/keywords/systematic-review |
| keywords[3].score | 0.5241824984550476 |
| keywords[3].display_name | Systematic review |
| keywords[4].id | https://openalex.org/keywords/disease |
| keywords[4].score | 0.5199912190437317 |
| keywords[4].display_name | Disease |
| keywords[5].id | https://openalex.org/keywords/leukemia |
| keywords[5].score | 0.4524187445640564 |
| keywords[5].display_name | Leukemia |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.44380003213882446 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/pandemic |
| keywords[7].score | 0.43466565012931824 |
| keywords[7].display_name | Pandemic |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.4258824586868286 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/medline |
| keywords[9].score | 0.38592982292175293 |
| keywords[9].display_name | MEDLINE |
| keywords[10].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[10].score | 0.3575984239578247 |
| keywords[10].display_name | Intensive care medicine |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.3468424081802368 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[12].score | 0.20880764722824097 |
| keywords[12].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[13].id | https://openalex.org/keywords/infectious-disease |
| keywords[13].score | 0.16462552547454834 |
| keywords[13].display_name | Infectious disease (medical specialty) |
| language | en |
| locations[0].id | doi:10.3389/fmed.2023.1280271 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2597052008 |
| locations[0].source.issn | 2296-858X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2296-858X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=False |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Medicine |
| locations[0].landing_page_url | https://doi.org/10.3389/fmed.2023.1280271 |
| locations[1].id | pmid:38327268 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38327268 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10847560 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10847560/pdf/fmed-10-1280271.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Front Med (Lausanne) |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10847560 |
| locations[3].id | pmh:oai:doaj.org/article:afb890a8d1f6448a9d6f9a6d17ee8736 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Frontiers in Medicine, Vol 10 (2024) |
| locations[3].landing_page_url | https://doaj.org/article/afb890a8d1f6448a9d6f9a6d17ee8736 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5083835926 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8967-433X |
| authorships[0].author.display_name | Elrazi Ali |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2801085205 |
| authorships[0].affiliations[0].raw_affiliation_string | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[0].institutions[0].id | https://openalex.org/I2801085205 |
| authorships[0].institutions[0].ror | https://ror.org/02yhdjx59 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2801085205 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Interfaith Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Elrazi A. Ali |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[1].author.id | https://openalex.org/A5065183217 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Anas Al-Sadi |
| authorships[1].countries | QA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I49828101 |
| authorships[1].affiliations[0].raw_affiliation_string | Internal Medicine Department, Hamad Medical Corporation, Qatar |
| authorships[1].institutions[0].id | https://openalex.org/I49828101 |
| authorships[1].institutions[0].ror | https://ror.org/02zwb6n98 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I49828101 |
| authorships[1].institutions[0].country_code | QA |
| authorships[1].institutions[0].display_name | Hamad Medical Corporation |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Anas Al-Sadi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Internal Medicine Department, Hamad Medical Corporation, Qatar |
| authorships[2].author.id | https://openalex.org/A5074469646 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Qusai Al-maharmeh |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210155827 |
| authorships[2].affiliations[0].raw_affiliation_string | Internal Medicine Department, Saint Michael's Medical Center, United States |
| authorships[2].institutions[0].id | https://openalex.org/I4210155827 |
| authorships[2].institutions[0].ror | https://ror.org/04ned8342 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210155827 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Saint Michael's Medical Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Qusai Al-maharmeh |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Internal Medicine Department, Saint Michael's Medical Center, United States |
| authorships[3].author.id | https://openalex.org/A5028711399 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9190-2891 |
| authorships[3].author.display_name | Eihab A. Subahi |
| authorships[3].countries | QA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I49828101 |
| authorships[3].affiliations[0].raw_affiliation_string | Internal Medicine Department, Hamad Medical Corporation, Qatar |
| authorships[3].institutions[0].id | https://openalex.org/I49828101 |
| authorships[3].institutions[0].ror | https://ror.org/02zwb6n98 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I49828101 |
| authorships[3].institutions[0].country_code | QA |
| authorships[3].institutions[0].display_name | Hamad Medical Corporation |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Eihab A. Subahi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Internal Medicine Department, Hamad Medical Corporation, Qatar |
| authorships[4].author.id | https://openalex.org/A5077263111 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Amulya Bellamkonda |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2801085205 |
| authorships[4].affiliations[0].raw_affiliation_string | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[4].institutions[0].id | https://openalex.org/I2801085205 |
| authorships[4].institutions[0].ror | https://ror.org/02yhdjx59 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2801085205 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Interfaith Medical Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Amulya Bellamkonda |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[5].author.id | https://openalex.org/A5109512112 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Madhumati Kalavar |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2801085205 |
| authorships[5].affiliations[0].raw_affiliation_string | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[5].institutions[0].id | https://openalex.org/I2801085205 |
| authorships[5].institutions[0].ror | https://ror.org/02yhdjx59 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2801085205 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Interfaith Medical Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Madhumati Kalavar |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[6].author.id | https://openalex.org/A5113013518 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Kalpana Panigrahi |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2801085205 |
| authorships[6].affiliations[0].raw_affiliation_string | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[6].institutions[0].id | https://openalex.org/I2801085205 |
| authorships[6].institutions[0].ror | https://ror.org/02yhdjx59 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2801085205 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Interfaith Medical Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kalpana Panigrahi |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Internal Medicine Department, Interfaith Medical Center/One Brooklyn Health, United States |
| authorships[7].author.id | https://openalex.org/A5018128825 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4454-5307 |
| authorships[7].author.display_name | Awni Alshurafa |
| authorships[7].countries | QA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210118835, https://openalex.org/I49828101 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Oncology-Hematology, National Center for Cancer Care and Research – Hamad Medical Corporation, Qatar |
| authorships[7].institutions[0].id | https://openalex.org/I49828101 |
| authorships[7].institutions[0].ror | https://ror.org/02zwb6n98 |
| authorships[7].institutions[0].type | nonprofit |
| authorships[7].institutions[0].lineage | https://openalex.org/I49828101 |
| authorships[7].institutions[0].country_code | QA |
| authorships[7].institutions[0].display_name | Hamad Medical Corporation |
| authorships[7].institutions[1].id | https://openalex.org/I4210118835 |
| authorships[7].institutions[1].ror | https://ror.org/02d4f9f51 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210118835, https://openalex.org/I49828101 |
| authorships[7].institutions[1].country_code | QA |
| authorships[7].institutions[1].display_name | National Center for Cancer Care and Research |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Awni Alshurafa |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Oncology-Hematology, National Center for Cancer Care and Research – Hamad Medical Corporation, Qatar |
| authorships[8].author.id | https://openalex.org/A5058357950 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-1144-8076 |
| authorships[8].author.display_name | Mohamed A. Yassin |
| authorships[8].countries | QA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210118835, https://openalex.org/I49828101 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Oncology-Hematology, National Center for Cancer Care and Research – Hamad Medical Corporation, Qatar |
| authorships[8].institutions[0].id | https://openalex.org/I49828101 |
| authorships[8].institutions[0].ror | https://ror.org/02zwb6n98 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I49828101 |
| authorships[8].institutions[0].country_code | QA |
| authorships[8].institutions[0].display_name | Hamad Medical Corporation |
| authorships[8].institutions[1].id | https://openalex.org/I4210118835 |
| authorships[8].institutions[1].ror | https://ror.org/02d4f9f51 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210118835, https://openalex.org/I49828101 |
| authorships[8].institutions[1].country_code | QA |
| authorships[8].institutions[1].display_name | National Center for Cancer Care and Research |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Mohamed A. Yassin |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Oncology-Hematology, National Center for Cancer Care and Research – Hamad Medical Corporation, Qatar |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=False |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | SARS-CoV-2 and chronic myeloid leukemia: a systematic review |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11215 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Chronic Myeloid Leukemia Treatments |
| related_works | https://openalex.org/W2394047154, https://openalex.org/W2044496404, https://openalex.org/W2144075887, https://openalex.org/W2990397977, https://openalex.org/W1490176706, https://openalex.org/W4242089967, https://openalex.org/W2607237549, https://openalex.org/W2052426387, https://openalex.org/W1971156147, https://openalex.org/W2364732766 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fmed.2023.1280271 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2597052008 |
| best_oa_location.source.issn | 2296-858X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2296-858X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=False |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fmed.2023.1280271 |
| primary_location.id | doi:10.3389/fmed.2023.1280271 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2597052008 |
| primary_location.source.issn | 2296-858X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2296-858X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1280271/pdf?isPublishedV2=False |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Medicine |
| primary_location.landing_page_url | https://doi.org/10.3389/fmed.2023.1280271 |
| publication_date | 2024-01-24 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3176366650, https://openalex.org/W3134965115, https://openalex.org/W3177851953, https://openalex.org/W2160811827, https://openalex.org/W3084528948, https://openalex.org/W3126442238, https://openalex.org/W3083100638, https://openalex.org/W3120242030, https://openalex.org/W3186644011, https://openalex.org/W3005079553, https://openalex.org/W3214003666, https://openalex.org/W3200948566, https://openalex.org/W3048630572, https://openalex.org/W4220987557, https://openalex.org/W4385798208, https://openalex.org/W4281262982, https://openalex.org/W4288179243, https://openalex.org/W4310379161, https://openalex.org/W3113734454, https://openalex.org/W3156070269, https://openalex.org/W4296328844, https://openalex.org/W2789227767, https://openalex.org/W2520543291, https://openalex.org/W3127921961, https://openalex.org/W2155484175, https://openalex.org/W2153866223, https://openalex.org/W3040548199, https://openalex.org/W1636999192, https://openalex.org/W2013366836, https://openalex.org/W2014839361, https://openalex.org/W4363673935, https://openalex.org/W4224248003, https://openalex.org/W4310700082, https://openalex.org/W3165656738, https://openalex.org/W4205483821 |
| referenced_works_count | 35 |
| abstract_inverted_index.2 | 6 |
| abstract_inverted_index.a | 70, 136, 239, 451 |
| abstract_inverted_index.13 | 335 |
| abstract_inverted_index.15 | 329 |
| abstract_inverted_index.18 | 155 |
| abstract_inverted_index.30 | 312 |
| abstract_inverted_index.33 | 225 |
| abstract_inverted_index.45 | 279 |
| abstract_inverted_index.In | 62, 120 |
| abstract_inverted_index.We | 189, 223 |
| abstract_inverted_index.an | 427 |
| abstract_inverted_index.at | 28 |
| abstract_inverted_index.be | 474 |
| abstract_inverted_index.in | 46, 49, 217, 250, 256, 263, 278, 294, 303, 328, 334, 397, 415, 437, 454 |
| abstract_inverted_index.is | 8, 69, 109, 215, 346, 433 |
| abstract_inverted_index.it | 108, 383 |
| abstract_inverted_index.no | 104, 284, 412 |
| abstract_inverted_index.of | 15, 22, 31, 58, 72, 77, 99, 148, 194, 227, 241, 286, 321, 343, 349, 356, 365, 369, 378, 389, 393, 404, 430 |
| abstract_inverted_index.on | 80, 464 |
| abstract_inverted_index.or | 354 |
| abstract_inverted_index.to | 38, 96, 209, 232, 272, 385, 418, 435, 449, 473, 478 |
| abstract_inverted_index.up | 208, 231 |
| abstract_inverted_index.we | 134 |
| abstract_inverted_index.20, | 211 |
| abstract_inverted_index.405 | 316 |
| abstract_inverted_index.682 | 242 |
| abstract_inverted_index.CML | 63, 243, 407, 444 |
| abstract_inverted_index.ICU | 333 |
| abstract_inverted_index.The | 17, 202, 213, 340, 457 |
| abstract_inverted_index.Two | 289 |
| abstract_inverted_index.WHO | 273 |
| abstract_inverted_index.all | 205 |
| abstract_inverted_index.and | 130, 145, 170, 182, 184, 235, 260, 281, 309, 332, 338 |
| abstract_inverted_index.any | 199 |
| abstract_inverted_index.are | 35, 424 |
| abstract_inverted_index.due | 95, 477 |
| abstract_inverted_index.end | 30 |
| abstract_inverted_index.era | 296, 320 |
| abstract_inverted_index.few | 373 |
| abstract_inverted_index.for | 116, 127, 198 |
| abstract_inverted_index.had | 44, 158 |
| abstract_inverted_index.has | 19, 445 |
| abstract_inverted_index.how | 111 |
| abstract_inverted_index.lot | 71 |
| abstract_inverted_index.new | 200 |
| abstract_inverted_index.not | 446 |
| abstract_inverted_index.the | 9, 12, 25, 29, 75, 78, 81, 97, 123, 191, 195, 251, 257, 264, 295, 304, 319, 347, 352, 363, 366, 370, 376, 379, 387, 390, 394, 402, 405, 479 |
| abstract_inverted_index.use | 98, 353 |
| abstract_inverted_index.was | 165, 269, 276, 311, 326 |
| abstract_inverted_index.who | 157 |
| abstract_inverted_index.(4%) | 330 |
| abstract_inverted_index.2019 | 187 |
| abstract_inverted_index.2023 | 234 |
| abstract_inverted_index.Beta | 52 |
| abstract_inverted_index.CML, | 93 |
| abstract_inverted_index.CML. | 400 |
| abstract_inverted_index.Most | 247 |
| abstract_inverted_index.Some | 84 |
| abstract_inverted_index.TKI; | 100 |
| abstract_inverted_index.TKIs | 357 |
| abstract_inverted_index.aged | 153 |
| abstract_inverted_index.been | 447 |
| abstract_inverted_index.care | 306 |
| abstract_inverted_index.case | 143, 146 |
| abstract_inverted_index.data | 237, 459 |
| abstract_inverted_index.from | 238 |
| abstract_inverted_index.have | 411, 450 |
| abstract_inverted_index.hold | 355 |
| abstract_inverted_index.lack | 348 |
| abstract_inverted_index.more | 36 |
| abstract_inverted_index.much | 112 |
| abstract_inverted_index.risk | 429 |
| abstract_inverted_index.seen | 277 |
| abstract_inverted_index.that | 461 |
| abstract_inverted_index.this | 344 |
| abstract_inverted_index.unit | 307 |
| abstract_inverted_index.were | 161, 249, 255, 262, 283, 293, 302, 315 |
| abstract_inverted_index.with | 55, 92, 122, 245, 399, 409, 426, 439, 443, 466 |
| abstract_inverted_index.(Alfa | 51 |
| abstract_inverted_index.(CML) | 470 |
| abstract_inverted_index.2019. | 16, 32 |
| abstract_inverted_index.2023. | 212 |
| abstract_inverted_index.April | 210, 233 |
| abstract_inverted_index.Delta | 53 |
| abstract_inverted_index.Items | 126 |
| abstract_inverted_index.There | 314 |
| abstract_inverted_index.about | 351 |
| abstract_inverted_index.above | 154 |
| abstract_inverted_index.acute | 2 |
| abstract_inverted_index.after | 318, 362 |
| abstract_inverted_index.among | 90, 299, 323 |
| abstract_inverted_index.blast | 265 |
| abstract_inverted_index.data. | 481 |
| abstract_inverted_index.death | 325 |
| abstract_inverted_index.eight | 261, 301 |
| abstract_inverted_index.first | 26 |
| abstract_inverted_index.lists | 193 |
| abstract_inverted_index.major | 341 |
| abstract_inverted_index.makes | 382 |
| abstract_inverted_index.needs | 472 |
| abstract_inverted_index.other | 101, 391, 419 |
| abstract_inverted_index.risk. | 456 |
| abstract_inverted_index.seven | 254 |
| abstract_inverted_index.since | 24 |
| abstract_inverted_index.still | 471 |
| abstract_inverted_index.terms | 174 |
| abstract_inverted_index.them, | 300, 324 |
| abstract_inverted_index.there | 68, 282 |
| abstract_inverted_index.total | 240 |
| abstract_inverted_index.using | 167 |
| abstract_inverted_index.virus | 10, 396 |
| abstract_inverted_index.which | 381, 432 |
| abstract_inverted_index.years | 156 |
| abstract_inverted_index.(11%). | 313 |
| abstract_inverted_index.(ICU), | 308 |
| abstract_inverted_index.Google | 171 |
| abstract_inverted_index.Method | 119 |
| abstract_inverted_index.Search | 173 |
| abstract_inverted_index.Severe | 1 |
| abstract_inverted_index.before | 297 |
| abstract_inverted_index.better | 88, 475 |
| abstract_inverted_index.cancer | 117 |
| abstract_inverted_index.caused | 20 |
| abstract_inverted_index.deaths | 23 |
| abstract_inverted_index.during | 358 |
| abstract_inverted_index.effect | 76, 463 |
| abstract_inverted_index.likely | 37, 94 |
| abstract_inverted_index.number | 220 |
| abstract_inverted_index.phase, | 253, 259 |
| abstract_inverted_index.phase. | 266 |
| abstract_inverted_index.review | 214, 345, 483 |
| abstract_inverted_index.search | 203 |
| abstract_inverted_index.severe | 40 |
| abstract_inverted_index.showed | 103 |
| abstract_inverted_index.study, | 406 |
| abstract_inverted_index.virus, | 372, 380 |
| abstract_inverted_index.Despite | 401 |
| abstract_inverted_index.Disease | 267 |
| abstract_inverted_index.English | 163 |
| abstract_inverted_index.PubMed, | 168 |
| abstract_inverted_index.Results | 222 |
| abstract_inverted_index.Reviews | 129 |
| abstract_inverted_index.SCOPUS, | 169 |
| abstract_inverted_index.cancers | 423 |
| abstract_inverted_index.causing | 11 |
| abstract_inverted_index.chronic | 149, 176, 179, 252, 467 |
| abstract_inverted_index.compare | 386 |
| abstract_inverted_index.degrees | 57 |
| abstract_inverted_index.details | 350 |
| abstract_inverted_index.develop | 39 |
| abstract_inverted_index.disease | 14, 18, 60, 186 |
| abstract_inverted_index.events. | 288 |
| abstract_inverted_index.hundred | 290 |
| abstract_inverted_index.include | 175 |
| abstract_inverted_index.limited | 480 |
| abstract_inverted_index.myeloid | 65, 150, 177, 468 |
| abstract_inverted_index.outcome | 388 |
| abstract_inverted_index.patient | 82, 442 |
| abstract_inverted_index.reports | 85, 102, 147, 285 |
| abstract_inverted_index.review. | 138 |
| abstract_inverted_index.series, | 144 |
| abstract_inverted_index.strains | 50 |
| abstract_inverted_index.studies | 197, 374 |
| abstract_inverted_index.unknown | 110 |
| abstract_inverted_index.variant | 377 |
| abstract_inverted_index.varying | 56 |
| abstract_inverted_index.(PRISMA) | 132 |
| abstract_inverted_index.(chronic | 64 |
| abstract_inverted_index.COVID-19 | 410 |
| abstract_inverted_index.However, | 441 |
| abstract_inverted_index.Numerous | 42 |
| abstract_inverted_index.Omicron) | 54 |
| abstract_inverted_index.PROSPERO | 218 |
| abstract_inverted_index.Scholar. | 172 |
| abstract_inverted_index.articles | 206, 226 |
| abstract_inverted_index.compared | 417 |
| abstract_inverted_index.effects. | 106 |
| abstract_inverted_index.expected | 434 |
| abstract_inverted_index.included | 196, 204 |
| abstract_inverted_index.increase | 414, 436, 453 |
| abstract_inverted_index.leukemia | 151, 469 |
| abstract_inverted_index.millions | 21 |
| abstract_inverted_index.outcome. | 83 |
| abstract_inverted_index.outcomes | 89 |
| abstract_inverted_index.pandemic | 27 |
| abstract_inverted_index.patients | 91, 152, 244, 248, 292, 317, 331, 398, 408, 438, 465 |
| abstract_inverted_index.provides | 115 |
| abstract_inverted_index.reported | 327, 448 |
| abstract_inverted_index.reviewed | 224 |
| abstract_inverted_index.reviews, | 142 |
| abstract_inverted_index.screened | 166 |
| abstract_inverted_index.searched | 190 |
| abstract_inverted_index.severity | 268 |
| abstract_inverted_index.studies, | 141 |
| abstract_inverted_index.syndrome | 4 |
| abstract_inverted_index.variants | 368, 392 |
| abstract_inverted_index.COVID-19. | 246, 440 |
| abstract_inverted_index.Mortality | 275 |
| abstract_inverted_index.Preferred | 124 |
| abstract_inverted_index.Reporting | 125 |
| abstract_inverted_index.according | 271 |
| abstract_inverted_index.articles. | 201 |
| abstract_inverted_index.available | 228, 458 |
| abstract_inverted_index.collected | 236 |
| abstract_inverted_index.conducted | 135 |
| abstract_inverted_index.criteria. | 274 |
| abstract_inverted_index.developed | 45 |
| abstract_inverted_index.different | 367 |
| abstract_inverted_index.difficult | 384 |
| abstract_inverted_index.included. | 162 |
| abstract_inverted_index.increased | 428 |
| abstract_inverted_index.indicates | 460 |
| abstract_inverted_index.infection | 160 |
| abstract_inverted_index.intensive | 305 |
| abstract_inverted_index.leukemia) | 66 |
| abstract_inverted_index.leukemia, | 178, 181 |
| abstract_inverted_index.mentioned | 375 |
| abstract_inverted_index.mortality | 310, 416 |
| abstract_inverted_index.mutations | 43 |
| abstract_inverted_index.patients, | 67, 280 |
| abstract_inverted_index.patients. | 118, 336 |
| abstract_inverted_index.potential | 87 |
| abstract_inverted_index.published | 207, 229 |
| abstract_inverted_index.reference | 192 |
| abstract_inverted_index.regarding | 74 |
| abstract_inverted_index.resulting | 48 |
| abstract_inverted_index.severity. | 61 |
| abstract_inverted_index.suggested | 86 |
| abstract_inverted_index.treatment | 79 |
| abstract_inverted_index.virulence | 59 |
| abstract_inverted_index.SARS-CoV-2 | 159, 183, 359, 371, 395 |
| abstract_inverted_index.Systematic | 128, 482 |
| abstract_inverted_index.accordance | 121 |
| abstract_inverted_index.appearance | 364 |
| abstract_inverted_index.associated | 425 |
| abstract_inverted_index.classified | 270 |
| abstract_inverted_index.conclusion | 339 |
| abstract_inverted_index.infection. | 360 |
| abstract_inverted_index.limitation | 342 |
| abstract_inverted_index.literature | 164, 230 |
| abstract_inverted_index.protection | 113 |
| abstract_inverted_index.registered | 216 |
| abstract_inverted_index.standards, | 133 |
| abstract_inverted_index.systematic | 137 |
| abstract_inverted_index.thrombosis | 455 |
| abstract_inverted_index.thrombotic | 287 |
| abstract_inverted_index.understood | 476 |
| abstract_inverted_index.(COVID-19). | 188 |
| abstract_inverted_index.Coronavirus | 185 |
| abstract_inverted_index.Limitations | 337 |
| abstract_inverted_index.SARS-CoV-2, | 47 |
| abstract_inverted_index.accelerated | 258 |
| abstract_inverted_index.controversy | 73 |
| abstract_inverted_index.coronavirus | 5, 13 |
| abstract_inverted_index.individuals | 34 |
| abstract_inverted_index.infections. | 41 |
| abstract_inverted_index.limitations | 403 |
| abstract_inverted_index.malignancy. | 421 |
| abstract_inverted_index.myelogenous | 180 |
| abstract_inverted_index.prospective | 140 |
| abstract_inverted_index.respiratory | 3 |
| abstract_inverted_index.significant | 105, 413, 452 |
| abstract_inverted_index.thrombosis, | 431 |
| abstract_inverted_index.(SARS-CoV-2) | 7 |
| abstract_inverted_index.COVID-19’s | 462 |
| abstract_inverted_index.Introduction | 0 |
| abstract_inverted_index.immunization | 114 |
| abstract_inverted_index.registration | 484 |
| abstract_inverted_index.vaccination; | 298, 322 |
| abstract_inverted_index.(registration | 219 |
| abstract_inverted_index.Additionally, | 107, 361 |
| abstract_inverted_index.Hematological | 422 |
| abstract_inverted_index.Meta-Analyses | 131 |
| abstract_inverted_index.hematological | 420 |
| abstract_inverted_index.seventy-seven | 291 |
| abstract_inverted_index.Retrospective, | 139 |
| abstract_inverted_index.CRD42022326674). | 221 |
| abstract_inverted_index.RecordID:326674. | 486 |
| abstract_inverted_index.Immunocompromised | 33 |
| abstract_inverted_index.https://www.crd.york.ac.uk/PROSPERO/display_record.php? | 485 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 9 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8899999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.77798211 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |